News | Artificial Intelligence | March 31, 2020

Infervision Launches Solution to Fight Against Coronavirus

The Chinese start-up company Infervision launches its AI-based solution InferRead CT Lung Covid-19 also in Europe

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 The Chinese start-up company Infervision launches its AI-based solution InferRead CT Lung Covid-19 also in Europe
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 The Chinese start-up company Infervision launches its AI-based solution InferRead CT Lung Covid-19 also in Europe

Professor Liming Xia, M.D.

March 31, 2020 — Lung infections generated by the coronavirus can be detected in computed tomography (CT) images. Radiologists at Tongji Hospital in Wuhan, China, had already determined this before the outbreak of the epidemic. The hospital, with 6,000 beds, was one of the first health centers in the world to equip itself with radiological artificial intelligence (AI) solutions from Infervision in 2015, and asked the company for support when the latest crisis broke out three months ago.

In close cooperation with the Zhongnan Hospital affiliated to the University of Wuhan, a specific diagnostic solution was developed and, thanks to the extensive knowledge of Infervision's engineers, implemented ultrafast with the company's own research platform InferScholar and thousands of data sets. The diagnostic system was first deployed in the emergency department and then, due to its excellent performance and accuracy, throughout the hospital. Currently, more than 30 hospitals are already using the solution.

Success at Wuhan Hospital

Professor Liming Xia, M.D., director of radiology at Wuhan Tongji Hospital and member of the editorial board of the Chinese Journal of Radiology, explained:

"Wuhan Tongji Hospital, Tongji Medical College affiliated to Huazhong University of Science and Technology are historic partners of Infervision. The Infervision team has done an incredible job working closely with us, 24 hours a day, 7 days a week, to deliver a workable diagnostic solution for COVID 19 pneumonia at horrendous speed."

Liming Xia summarizes the benefits of InferRead CT Lung Covid-19 as following:

1. Reducing the risk of cross-contamination and pressure on staff: The hospitals are massively relieved. Patients wait for hours for examinations and results from overworked doctors. Artificial intelligence can help to reduce the workload and streamline the way care is provided.

2. Increase confidence in the diagnosis: By automatically measuring and quantifying the density, morphology and volume of lesions, artificial intelligence can provide an immediate and more reliable diagnosis.

3. The development of the disease can be predicted by comparing the scans: The automatic comparison of lesions helps doctors to monitor the patient's condition and development, while at the same time evaluating the effectiveness of treatments more accurately and quickly.

Growing interest in Europe

The Campus Bio-Medico University Hospital (UCBM) in Rome InferRead is the first European customer to use CT Lung Covid-19. The system was implemented in just a few hours. Now that screening and early diagnosis have become a priority for pandemic containment, UCBM is rapidly identifying potential COVID-19 patients, minimizing the risk of further infection.

The solution is capable of providing an early indication within seconds, and the entire analysis of a CT scan takes less than 50 seconds.

For data protection reasons, the system is usually installed directly in the hospital. Additionally, and especially for smaller hospitals, a cloud solution is being prepared.

Compared to other test procedures, the solution has eminent advantages:

  • Early diagnosis even for infections without symptoms
  • Follow-up of the disease
  • Quantification of volume and density
  • Speed
  • Independence regarding reagents, tests, laboratories and transport
  • more efficient triage and thus reduced risk of infection
  • high constant quality with convincing performance features

 

Imaging CT scan: InferRead CT Lung Covid-19 displays the focus of infection in images and calculates volume, density and prognosis. The text of the findings is also generated fully automatically to relieve the physicians.

China as a role model?

Bruno Schär, managing director of Infervision Switzerland, reports on his impressions from China in December 2019:

"I am impressed by the speed and professionalism I have seen at the People’s Hospital affliated to Peking University. Because of large number of inflow of patients, any diagnosis must be made efficiently. With the help of our AI solutions, it takes only a few minutes to use a CT room - about five times less than in Western countries. We're talking about highly efficient medicine at affordable prices. The West, it seems, still has a lot to learn in order to stop the trend of constantly rising health care costs.”

For more information: www.infervision.com

Related Coronavirus Content:

VIDEO: Use of Telemedicine in Medical Imaging During COVID-19

VIDEO: How China Leveraged Health IT to Combat COVID-19

 CDRH Issues Letter to Industry on COVID-19

Qure.ai Launches Solutions to Help Tackle COVID19 

ASRT Deploys COVID-19 Resources for Educational Programs

Study Looks at CT Findings of COVID-19 Through Recovery

VIDEO: Imaging COVID-19 With Point-of-Care Ultrasound (POCUS)

The Cardiac Implications of Novel Coronavirus

CT Provides Best Diagnosis for Novel Coronavirus (COVID-19)

Radiology Lessons for Coronavirus From the SARS and MERS Epidemics

Deployment of Health IT in China’s Fight Against the COVID-19 Epidemic

Emerging Technologies Proving Value in Chinese Coronavirus Fight

Radiologists Describe Coronavirus CT Imaging Features

Coronavirus Update from the FDA

CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia

CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia 

Find more related clinical content Coronavirus (COVID-19)

Related Content

Although it is likely that existing ultrasound systems will be repurposed to treat COVID-19 patients, growth is still expected as companies plan to ramp up production. The ultrasound systems market will therefore outpace other diagnostic imaging such as computed tomography (CT) and magnetic resonance imaging (MRI). Leading data and analytics company GlobalData forecasts the market will reach $6bn by 2028, but increased usage due to COVID-19 is anticipated have a tangible effect.
News | Ultrasound Imaging | June 05, 2020
June 5, 2020 — Although it is likely that existing...
Stephen M. Hahn, M.D., Commissioner of Food and Drugs - Food and Drug Administration, discussed The COVID-19 Pandemic — Finding Solutions, Applying Lessons Learned, on June 1

Stephen M. Hahn, M.D., Commissioner of Food and Drugs - Food and Drug Administration

News | Coronavirus (COVID-19) | June 05, 2020
June 5, 2020 — The following speech was delivere
Chief among the myriad practical updates to minimize risks for patients and imaging personnel alike is a tiered approach for delaying both outpatient and inpatient cross-sectional interventional procedures

For procedural delays that will not adversely affect patient outcome, Fananapazir and colleagues proposed the following tiered approach for both outpatient and inpatient scenarios: urgent procedures, procedures that should be performed within 2 weeks, procedures that should be performed within 2 months, and procedures that can safely be delayed 2 or 6 months. Courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | June 05, 2020
June 5, 2020 — An...
This is Figure 2 from the article in Radiology: Acute encephalopathy. A 60 year-old-man without history of seizures presenting with convulsion. (A-B) Multifocal areas of FLAIR hyperintensity in the right cerebellum (arrows in A), left anterior cingular cortex and superior frontal gyrus (arrows in B). (C-D) Restricted diffusion in the left anterior cingulate cortex, superior frontal and middle temporal gyrus (arrows in D) and right cerebellum (arrows in E), consistent with cerebellar diaschisis. F)  #COVID19

This is Figure 2 from the article in Radiology: Acute encephalopathy. A 60 year-old-man without history of seizures presenting with convulsion. (A-B) Multifocal areas of FLAIR hyperintensity in the right cerebellum (arrows in A), left anterior cingular cortex and superior frontal gyrus (arrows in B). (C-D) Restricted diffusion in the left anterior cingulate cortex, superior frontal and middle temporal gyrus (arrows in D) and right cerebellum (arrows in E), consistent with cerebellar diaschisis. F) No hemosiderin deposits in gradient echo sequences.

Feature | Coronavirus (COVID-19) | June 02, 2020 | Dave Fornell, Editor
Four recent radiology studies, from New York, Italy, Iran and China, show how...
Developed by medical AI company Lunit, Software detects breast cancer with 97% accuracy; Study in Lancet Digital Health shows that Lunit INSIGHT MMG-aided radiologists showed an increase in sensitivity

Lunit INSIGHT MMG

News | Artificial Intelligence | June 02, 2020
June 2, 2020 — Lunit announced that its artificia...
Nuclear Cardiology Optimistic About Return to Pre-COVID-19 Exam Levels. An American Society of Nuclear Cardiology (ASNC) member survey are confident nuclear cardiology volumes will return to pre-pandemic levels. #COVID19 #SARScov2
News | Nuclear Imaging | June 01, 2020
June 1, 2020 — While acknowledging the challenges their specialty is facing, more than two-thirds of respondents to a
AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire)

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire).

News | Artificial Intelligence | May 29, 2020
May 29, 2020 — GE Healthcare announced U.S.
Largest case series (n=30) to date yields high frequency (77%) of negative chest CT findings among pediatric patients (10 months-18 years) with COVID-19, while also suggesting common findings in subset of children with positive CT findings

A and B, Unenhanced chest CT scans show minimal GGOs (right lower and left upper lobes) (arrows) and no consolidation. Only two lobes were affected, and CT findings were assigned CT severity score of 2. Image courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | May 29, 2020
May 29, 2020 — An investigation published open-access in the ...
The paradox is that COVID-19 has manifested the critical need for exactly what the rules require: advancement of interoperability and digital online access to clinical data and imaging, at scale, for care coordination and infection control.

The paradox is that COVID-19 has manifested the critical need for exactly what the rules require: advancement of interoperability and digital online access to clinical data and imaging, at scale, for care coordination and infection control. Getty Images

Feature | Coronavirus (COVID-19) | May 28, 2020 | By Matthew A. Michela
One year after being proposed, federal rules to advance interoperability in healthcare and create easier access for p